tetano
Editor, Senior Moderator
Cureus
. 2022 Jul 13;14(7):e26825.
doi: 10.7759/cureus.26825. eCollection 2022 Jul.
Acute Portal Vein Thrombosis Secondary to COVID-19 Vaccination
Matthew L Repp[SUP] 1 [/SUP], Seth Cohen[SUP] 2 [/SUP], Caitlin Kibbey[SUP] 2 [/SUP]
Affiliations
Abstract
Portal vein thrombosis (PVT) is a partial or complete occlusion of the hepatic portal vein most frequently seen in patients with cirrhotic liver disease. Various non-cirrhotic conditions including inherited prothrombic blood disorders, neoplasms, and inflammatory diseases create hypercoagulable states that predispose individuals to blood clotting. Rarely does an exhaustive workup leave the etiology of a PVT unknown or unclear, and even more uncommon is a potential new etiology suspected. Our patient is a 34-year-old female, with no significant risk factors for pathologic clotting, who was diagnosed with an acute PVT several days after receiving the Moderna coronavirus disease 2019 (COVID-19) vaccine.
Keywords: coronavirus; covid-19; oral contraceptive; portal venous thrombosis; vaccine.
. 2022 Jul 13;14(7):e26825.
doi: 10.7759/cureus.26825. eCollection 2022 Jul.
Acute Portal Vein Thrombosis Secondary to COVID-19 Vaccination
Matthew L Repp[SUP] 1 [/SUP], Seth Cohen[SUP] 2 [/SUP], Caitlin Kibbey[SUP] 2 [/SUP]
Affiliations
- PMID: 35971366
- PMCID: PMC9372381
- DOI: 10.7759/cureus.26825
Abstract
Portal vein thrombosis (PVT) is a partial or complete occlusion of the hepatic portal vein most frequently seen in patients with cirrhotic liver disease. Various non-cirrhotic conditions including inherited prothrombic blood disorders, neoplasms, and inflammatory diseases create hypercoagulable states that predispose individuals to blood clotting. Rarely does an exhaustive workup leave the etiology of a PVT unknown or unclear, and even more uncommon is a potential new etiology suspected. Our patient is a 34-year-old female, with no significant risk factors for pathologic clotting, who was diagnosed with an acute PVT several days after receiving the Moderna coronavirus disease 2019 (COVID-19) vaccine.
Keywords: coronavirus; covid-19; oral contraceptive; portal venous thrombosis; vaccine.